Home/Hedge Fund Intelligence/BioAge Labs, Inc.
Nasdaq: BIOAStockForm 13F30 Jun 2026

Hedge funds that hold BioAge Labs, Inc. Nasdaq: BIOA

CUSIP 09077V100 · who reports it, how much, and how much it matters to them

26 of the 720 hedge fund managers we track reported shares of BioAge Labs, Inc. (Nasdaq: BIOA) on Form 13F for 30 June 2026. Between them they reported USD 352m. The largest position belongs to Cormorant Asset Management, at USD 59m. The manager with the most riding on it is Octagon Capital Advisors, where it is 3.9% of the reported book.

Managers reporting it26of 720 we track
Value they reportUSD 352mshares only, 30 Jun 2026
Funds they run309with a file on PPLI.com
Largest positionUSD 59mCormorant Asset Management
Typical weight0.0%median share of a manager's book
Heaviest weight3.9%Octagon Capital Advisors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

26 managers, USD 352m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports BioAge Labs, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Cormorant Asset Management1 fund on PPLI.comUSD 59m3.0%
2Sofinnova Investments1 fund on PPLI.comUSD 56m2.9%
3Octagon Capital Advisors1 fund on PPLI.comUSD 43m3.9%
4Ra Capital Management1 fund on PPLI.comUSD 41m0.4%
5Polar Capital LLP26 funds on PPLI.comUSD 26m0.1%
6Braidwell12 funds on PPLI.comUSD 25m0.9%
7Orbimed Advisors1 fund on PPLI.comUSD 18m0.3%
8D. E. Shaw & Co.15 funds on PPLI.comUSD 18m0.0%
9Balyasny Asset Management25 funds on PPLI.comUSD 17m0.0%
10Walleye Capital8 funds on PPLI.comUSD 8.7m0.0%
11Adage Capital Management1 fund on PPLI.comUSD 7.4m0.0%
12Millennium Management6 funds on PPLI.comUSD 5.5m0.0%
13Sphera Funds Management1 fund on PPLI.comUSD 5.2m0.7%
14Yiheng Capital Management1 fund on PPLI.comUSD 4.2m1.4%
15Renaissance Technologies13 funds on PPLI.comUSD 4.1m0.0%
16Burkehill Global Management5 funds on PPLI.comUSD 2.5m0.1%
17Citadel Advisors32 funds on PPLI.comUSD 1.9m0.0%
18Squarepoint Ops7 funds on PPLI.comUSD 1.7m0.0%
19Two Sigma Investments35 funds on PPLI.comUSD 1.5m0.0%
20Boothbay Fund Management2 funds on PPLI.comUSD 1.5m0.0%
21Persistent Asset Partners10 funds on PPLI.comUSD 913,0000.3%
22Voloridge Investment Management6 funds on PPLI.comUSD 866,0000.0%
23Marshall Wace LLP84 funds on PPLI.comUSD 778,0000.0%
24Wexford Capital8 funds on PPLI.comUSD 632,0000.1%
25Verdad Advisers6 funds on PPLI.comUSD 426,0000.4%
26Engineers Gate Manager1 fund on PPLI.comUSD 344,0000.0%
Next: where it matters most
Where it matters most

For Octagon Capital Advisors it is 3.9% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Octagon Capital AdvisorsUSD 43m3.9%
2Cormorant Asset ManagementUSD 59m3.0%
3Sofinnova InvestmentsUSD 56m2.9%
4Yiheng Capital ManagementUSD 4.2m1.4%
5BraidwellUSD 25m0.9%
6Sphera Funds ManagementUSD 5.2m0.7%
7Verdad AdvisersUSD 426,0000.4%
8Ra Capital ManagementUSD 41m0.4%
9Orbimed AdvisorsUSD 18m0.3%
10Persistent Asset PartnersUSD 913,0000.3%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds BioAge Labs, Inc.

What is the ticker symbol of BioAge Labs, Inc.?

BioAge Labs, Inc. trades under the symbol BIOA on the Nasdaq. Its CUSIP, the code used on Form 13F, is 09077V100.

Which hedge funds own BioAge Labs, Inc. (Nasdaq: BIOA)?

26 of the 720 hedge fund managers PPLI.com tracks reported BioAge Labs, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Cormorant Asset Management (USD 59m), Sofinnova Investments (USD 56m), Octagon Capital Advisors (USD 43m), Ra Capital Management (USD 41m) and Polar Capital LLP (USD 26m).

How many hedge funds hold BioAge Labs, Inc.?

26 managers in our coverage reported it, and between them they run 309 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on BioAge Labs, Inc.?

Octagon Capital Advisors, where the position was 3.9% of the reported 13F book at 30 June 2026.

Does this show who is short BioAge Labs, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with BioAge Labs, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.